BDBM683754 6-(6-chloro-4-{3,6- diazabicyclo[3.2.2]nonan- 3-yl}-8-fluoro-2-{[(2S)- 1-methylpyrrolidin-2- yl]methoxy}quinazolin-7- yl)-4-methyl-5- (trifluoromethyl)pyridin- 2-amine::US20240217982, Example 2-2

SMILES CN1CCC[C@H]1COc1nc(N2CC3CCC(C2)NC3)c2cc(Cl)c(c(F)c2n1)-c1nc(N)cc(C)c1C(F)(F)F

InChI Key InChIKey=GREPLVKAGJQJJM-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 683754   

TargetGTPase KRas [G12D](Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM683754(US20240217982, Example 2-2 | 6-(6-chloro-4-{3,6- d...)
Affinity DataIC50: 140nMAssay Description:Recombinant GDP-loaded KRAS G12D (20 nM) was treated with compound at room temperature for 20 minutes in assay buffer (10 mM Hepes pH 7.4, 150 mM NaC...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent